Antioxidant enzyme gene transfer for ischemic diseases

Advanced Drug Delivery Reviews

Volumn 61, Issue 4, 2009, Pages 351-363

  Wu, Jian ^a   Hecker, James G ^b   Chiamvimonvat, Nipavan ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antioxidant; Catalase; Central nervous system; Gene therapy; Gene transfer; Glutathione peroxidase; Heart; Heme oxygenase 1; Intestine; Ischemia reperfusion; Ischemic injury; Liver; Lung; NADPH oxidase; Oxidant stress; Reactive oxygen species; Superoxide dismutase; Xanthine oxidase

Indexed keywords

ANTIOXIDANT; CATALASE; CENTRAL NERVOUS SYSTEM; GENE THERAPY; GLUTATHIONE PEROXIDASE; HEART; HEME OXYGENASE-1; INTESTINE; ISCHEMIA/REPERFUSION; ISCHEMIC INJURY; LUNG; NADPH OXIDASE; OXIDANT STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ENZYME INHIBITION; HEMOGLOBIN; HISTOLOGY; LIVER; OXIDANTS; OXYGEN; PORPHYRINS;

GENE TRANSFER;

ADENOVIRUS VECTOR; ANTIOXIDANT; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; ERYTHROPOIETIN; GLUTATHIONE PEROXIDASE; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; HERPESVIRUS VECTOR; LENTIVIRUS VECTOR; LIPOSOME; M 40401; MANGANESE SUPEROXIDE DISMUTASE; NANOPARTICLE; PARVOVIRUS VECTOR; PLASMID DNA; POLYMER; REACTIVE OXYGEN METABOLITE; RETROVIRUS VECTOR; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CELL PROTECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG DISTRIBUTION; DRUG UPTAKE; EXCITOTOXICITY; GENE THERAPY; GENE TRANSFER; INTESTINE ISCHEMIA; ISCHEMIA; LIPOSOMAL GENE DELIVERY SYSTEM; LIVER ISCHEMIA; LUNG DISEASE; MESENTERIC ARTERY OCCLUSION; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIATION ENTEROPATHY; RAT; REPERFUSION INJURY; REVIEW; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIOXIDANTS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; ISCHEMIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 64149131919     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.01.005     Document Type: Review

References (159)

1. Karlsson K., Sandstrom J., Edlund A., and Marklund S.L. Turnover of extracellular-superoxide dismutase in tissues. Lab. Invest. 70 (1994) 705-710
2. Venugopal S.K., Wu J., Catana A.M., Eisenbud L., He S.Q., Duan Y.Y., Follenzi A., and Zern M.A. Lentivirus-mediated superoxide dismutase1 gene delivery protects against oxidative stress-induced liver injury in mice. Liver Int. 27 (2007) 1311-1322
3. Zhang Y., Gu J., Zhao L., He L., Qian W., Wang J., Wang Y., Qian Q., Qian C., Wu J., and Liu X.Y. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy. Cancer Res. 66 (2006) 4291-4298
4. Wu J., Liu L., Yen R.D., Catana A., Nantz M.H., and Zern M.A. Liposome-mediated extracellular superoxide dismutase gene delivery protects against acute liver injury in mice. Hepatology 40 (2004) 195-204
5. Marklund S.L. Extracellular superoxide dismutase. Methods. Enzymol. 349 (2002) 74-80
6. Winterbourn C.C., and Stern A. Human red cells scavenge extracellular hydrogen peroxide and inhibit formation of hypochlorous acid and hydroxyl radical. J. Clin. Invest. 80 (1987) 1486-1491
7. Wu J., Danielsson A., and Zern M.A. Toxicity of hepatotoxins: new insights into mechanisms and therapy. Expert. Opin. Investig. Drugs. 8 (1999) 585-607
8. Arteel G.E. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 124 (2003) 778-790
9. He S.Q., Zhang Y.H., Venugopal S.K., Dicus C.W., Perez R.V., Ramsamooj R., Nantz M.H., Zern M.A., and Wu J. Delivery of antioxidative enzyme genes protects against ischemia/reperfusion-induced liver injury in mice. Liver. Transpl. 12 (2006) 1869-1879
10. Hoehn B., Yenari M.A., Sapolsky R.M., and Steinberg G.K. Glutathione peroxidase overexpression inhibits cytochrome C release and proapoptotic mediators to protect neurons from experimental stroke. Stroke 34 (2003) 2489-2494
11. Zhu H.L., Stewart A.S., Taylor M.D., Vijayasarathy C., Gardner T.J., and Sweeney H.L. Blocking free radical production via adenoviral gene transfer decreases cardiac ischemia-reperfusion injury. Mol. Ther. 2 (2000) 470-475
12. Loboda A., Jazwa A., Grochot-Przeczek A., Rutkowski A.J., Cisowski J., Agarwal A., Jozkowicz A., and Dulak J. Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox. Signal. 10 (2008) 1767-1812
13. Hegazy K.A., Dunn M.W., and Sharma S.C. Functional human heme oxygenase has a neuroprotective effect on adult rat ganglion cells after pressure-induced ischemia. Neuroreport 11 (2000) 1185-1189
14. Liu X., Simpson J.A., Brunt K.R., Ward C.A., Hall S.R., Kinobe R.T., Barrette V., Tse M.Y., Pang S.C., Pachori A.S., Dzau V.J., Ogunyankin K.O., and Melo L.G. Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H48-59
15. Pachori A.S., Melo L.G., Zhang L., Solomon S.D., and Dzau V.J. Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery. J. Am. Coll. Cardiol. 47 (2006) 635-643
16. Blydt-Hansen T.D., Katori M., Lassman C., Ke B., Coito A.J., Iyer S., Buelow R., Ettenger R., Busuttil R.W., and Kupiec-Weglinski J.W. Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury. J. Am. Soc. Nephrol. 14 (2003) 745-754
17. Pachori A.S., Melo L.G., Hart M.L., Noiseux N., Zhang L., Morello F., Solomon S.D., Stahl G.L., Pratt R.E., and Dzau V.J. Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 12282-12287
18. McCarter S.D., Badhwar A., Scott J.R., Akyea T.G., Bihari A., Dungey A.A., Harris K.A., and Potter R.F. Remote liver injury is attenuated by adenovirus-mediated gene transfer of heme oxygenase-1 during the systemic inflammatory response syndrome. Microcirculation 11 (2004) 587-595
19. Sass G., Soares M.C., Yamashita K., Seyfried S., Zimmermann W.H., Eschenhagen T., Kaczmarek E., Ritter T., Volk H.D., and Tiegs G. Heme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice. Hepatology 38 (2003) 909-918
20. Amersi F., Buelow R., Kato H., Ke B., Coito A.J., Shen X.D., Zhao D., Zaky J., Melinek J., Lassman C.R., Kolls J.K., Alam J., Ritter T., Volk H.D., Farmer D.G., Ghobrial R.M., Busuttil R.W., and Kupiec-Weglinski J.W. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J. Clin. Invest. 104 (1999) 1631-1639
21. Pachori A.S., Melo L.G., Zhang L., Solomon S.D., and Dzau V.J. Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery. J. Am. Coll. Cardiol. 47 (2006) 635-643
22. Yen R.D., Zern M.A., and Wu J. Molecular therapy for hepatic fibrosis. In: Weber D. (Ed). Trends in Chemotherapy Research (2006), Nova Science Publishers, Inc, Hauppauge, N.Y. 1-23
23. Brunetti-Pierri N., and Ng P. Progress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors. Gene Ther. 15 (2008) 553-560
24. Hartman Z.C., Appledorn D.M., and Amalfitano A. Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res. 132 (2008) 1-14
25. Schultz B.R., and Chamberlain J.S. Recombinant adeno-associated virus transduction and integration. Mol. Ther. 16 (2008) 1189-1199
26. Fehse B., and Roeder I. Insertional mutagenesis and clonal dominance: biological and statistical considerations. Gene Ther. 15 (2008) 143-153
27. Cockrell A.S., and Kafri T. Gene delivery by lentivirus vectors. Mol. Biotechnol. 36 (2007) 184-204
28. Hurttila H., Koponen J.K., Kansanen E., Jyrkkanen H.K., Kivela A., Kylatie R., Yla-Herttuala S., and Levonen A.L. Oxidative stress-inducible lentiviral vectors for gene therapy. Gene Ther. 15 (2008) 1271-1279
29. Lachmann R. Herpes simplex virus-based vectors. Int. J. Exp. Pathol. 85 (2004) 177-190
30. Liu F., Song Y., and Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6 (1999) 1258-1266
31. Suda T., and Liu D. Hydrodynamic gene delivery: its principles and applications. Mol. Ther. 15 (2007) 2063-2069
32. Alino S.F., Herrero M.J., Noguera I., Dasi F., and Sanchez M. Pig liver gene therapy by noninvasive interventionist catheterism. Gene Ther. 14 (2007) 334-343
33. Khorsandi S.E., Bachellier P., Weber J.C., Greget M., Jaeck D., Zacharoulis D., Rountas C., Helmy S., Helmy A., Al-Waracky M., Salama H., Jiao L., Nicholls J., Davies A.J., Levicar N., Jensen S., and Habib N. Minimally invasive and selective hydrodynamic gene therapy of liver segments in the pig and human. Cancer Gene Ther. 15 (2008) 225-230
34. Brunetti-Pierri N., Stapleton G.E., Palmer D.J., Zuo Y., Mane V.P., Finegold M.J., Beaudet A.L., Leland M.M., Mullins C.E., and Ng P. Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy. Mol. Ther. 15 (2007) 732-740
35. Wolff J.A., and Rozema D.B. Breaking the bonds: non-viral vectors become chemically dynamic. Mol. Ther. 16 (2008) 8-15
36. Wu J., Nantz M.H., and Zern M.A. Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Front. Biosci. 7 (2002) d717-25
37. Li W., and Szoka Jr. F.C. Lipid-based nanoparticles for nucleic acid delivery. Pharm. Res. 24 (2007) 438-449
38. Abrescia P., and Golino P. Free radicals and antioxidants in cardiovascular diseases. Expert Rev. Cardiovasc. Ther. 3 (2005) 159-171
39. Cantor E.J., Mancini E.V., Seth R., Yao X.H., and Netticadan T. Oxidative stress and heart disease: cardiac dysfunction, nutrition, and gene therapy. Curr. Hypertens. Rep. 5 (2003) 215-220
40. Dhalla N.S., Temsah R.M., and Netticadan T. Role of oxidative stress in cardiovascular diseases. J. Hypertens. 18 (2000) 655-673
41. Higashi Y., Nishioka K., Umemura T., Chayama K., and Yoshizumi M. Oxidative stress, endothelial function and angiogenesis induced by cell therapy and gene therapy. Curr. Pharm. Biotechnol. 7 (2006) 109-116
42. Levonen A.L., Vahakangas E., Koponen J.K., and Yla-Herttuala S. Antioxidant gene therapy for cardiovascular disease: current status and future perspectives. Circulation 117 (2008) 2142-2150
43. Zima A.V., and Blatter L.A. Redox regulation of cardiac calcium channels and transporters. Cardiovasc. Res. 71 (2006) 310-321
44. + channels. Circ. Res. 76 (1995) 325-334
45. 2+ channels by S-nitrosothiol nitric oxide donors. Circ. Res. 81 (1997) 742-752
46. Gill J.S., McKenna W.J., and Camm A.J. Free radicals irreversibly decrease Ca2+ currents in isolated guinea-pig ventricular myocytes. Eur. J. Pharmacol. 292 (1995) 337-340
47. Sabaawy H.E., Zhang F., Nguyen X., ElHosseiny A., Nasjletti A., Schwartzman M., Dennery P., Kappas A., and Abraham N.G. Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension 38 (2001) 210-215
48. Melo L.G., Agrawal R., Zhang L., Rezvani M., Mangi A.A., Ehsan A., Griese D.P., Dell'Acqua G., Mann M.J., Oyama J., Yet S.F., Layne M.D., Perrella M.A., and Dzau V.J. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 105 (2002) 602-607
49. Liu X., Pachori A.S., Ward C.A., Davis J.P., Gnecchi M., Kong D., Zhang L., Murduck J., Yet S.F., Perrella M.A., Pratt R.E., Dzau V.J., and Melo L.G. Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function. Faseb J. 20 (2006) 207-216
50. Tulis D.A., Durante W., Liu X., Evans A.J., Peyton K.J., and Schafer A.I. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 104 (2001) 2710-2715
51. Duckers H.J., Boehm M., True A.L., Yet S.F., San H., Park J.L., Clinton Webb R., Lee M.E., Nabel G.J., and Nabel E.G. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat. Med. 7 (2001) 693-698
52. Juan S.H., Lee T.S., Tseng K.W., Liou J.Y., Shyue S.K., Wu K.K., and Chau L.Y. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104 (2001) 1519-1525
53. Chu Y., Iida S., Lund D.D., Weiss R.M., DiBona G.F., Watanabe Y., Faraci F.M., and Heistad D.D. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ. Res. 92 (2003) 461-468
54. Laukkanen M.O., Kivela A., Rissanen T., Rutanen J., Karkkainen M.K., Leppanen O., Brasen J.H., and Yla-Herttuala S. Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloon-denuded rabbit aorta. Circulation 106 (2002) 1999-2003
55. Brasen J.H., Leppanen O., Inkala M., Heikura T., Levin M., Ahrens F., Rutanen J., Pietsch H., Bergqvist D., Levonen A.L., Basu S., Zeller T., Kloppel G., Laukkanen M.O., and Yla-Herttuala S. Extracellular superoxide dismutase accelerates endothelial recovery and inhibits in-stent restenosis in stented atherosclerotic Watanabe heritable hyperlipidemic rabbit aorta. J. Am. Coll. Cardiol. 50 (2007) 2249-2253
56. Li Q., Bolli R., Qiu Y., Tang X.L., Guo Y., and French B.A. Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation 103 (2001) 1893-1898
57. Agrawal R.S., Muangman S., Layne M.D., Melo L., Perrella M.A., Lee R.T., Zhang L., Lopez-Ilasaca M., and Dzau V.J. Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival. Gene Ther. 11 (2004) 962-969
58. Yang J., Marden J.J., Fan C., Sanlioglu S., Weiss R.M., Ritchie T.C., Davisson R.L., and Engelhardt J.F. Genetic redox preconditioning differentially modulates AP-1 and NF kappa B responses following cardiac ischemia/reperfusion injury and protects against necrosis and apoptosis. Mol. Ther. 7 (2003) 341-353
59. Woo Y.J., Zhang J.C., Vijayasarathy C., Zwacka R.M., Englehardt J.F., Gardner T.J., and Sweeney H.L. Recombinant adenovirus-mediated cardiac gene transfer of superoxide dismutase and catalase attenuates postischemic contractile dysfunction. Circulation 98 (1998) II255-60 discussion II260-1
60. Berg K., Wiseth R., Bjerve K., Brurok H., Gunnes S., Skarra S., Jynge P., and Basu S. Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release. Free Radic. Res. 38 (2004) 517-525
61. Tsimikas S., Lau H.K., Han K.R., Shortal B., Miller E.R., Segev A., Curtiss L.K., Witztum J.L., and Strauss B.H. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 109 (2004) 3164-3170
62. Leite P.F., Danilovic A., Moriel P., Dantas K., Marklund S., Dantas A.P., and Laurindo F.R. Sustained decrease in superoxide dismutase activity underlies constrictive remodeling after balloon injury in rabbits. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 2197-2202
63. Daemen J., Wenaweser P., Tsuchida K., Abrecht L., Vaina S., Morger C., Kukreja N., Juni P., Sianos G., Hellige G., van Domburg R.T., Hess O.M., Boersma E., Meier B., Windecker S., and Serruys P.W. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
64. Pfisterer M.E. Late stent thrombosis after drug-eluting stent implantation for acute myocardial infarction: a new red flag is raised. Circulation 118 (2008) 1117-1119
65. Mutlu G.M., Ahkmedov A.T., Lum H., and Factor P. Potential genetic therapies for acute lung injury. Curr. Gene Ther. 4 (2004) 487-495
66. Wilkes D.S., Egan T.M., and Reynolds H.Y. Lung transplantation: opportunities for research and clinical advancement. Am. J. Respir. Crit. Care Med. 172 (2005) 944-955
67. Kozower B.D., Christofidou-Solomidou M., Sweitzer T.D., Muro S., Buerk D.G., Solomides C.C., Albelda S.M., Patterson G.A., and Muzykantov V.R. Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat. Biotechnol. 21 (2003) 392-398
68. Fiser S.M., Tribble C.G., Long S.M., Kaza A.K., Cope J.T., Laubach V.E., Kern J.A., and Kron I.L. Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J. Thorac. Cardiovasc. Surg. 121 (2001) 1069-1075
69. Nowak K., Weih S., Metzger R., Albrecht II R.F., Post S., Hohenberger P., Gebhard M.M., and Danilov S.M. Immunotargeting of catalase to lung endothelium via anti-angiotensin-converting enzyme antibodies attenuates ischemia-reperfusion injury of the lung in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 293 (2007) L162-169
70. Liu H., Liu L., Fletcher B.S., and Visner G.A. Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis. Faseb J. 20 (2006) 2384-2386
71. Liu H., Liu L., and Visner G.A. Nonviral gene delivery with indoleamine 2,3-dioxygenase targeting pulmonary endothelium protects against ischemia-reperfusion injury. Am. J. Transplant 7 (2007) 2291-2300
72. Otterbein L.E., Lee P.J., Chin B.Y., Petrache I., Camhi S.L., Alam J., and Choi A.M. Protective effects of heme oxygenase-1 in acute lung injury. Chest 116 (1999) 61S-63S
73. Guo H., Epperly M.W., Bernarding M., Nie S., Gretton J., Jefferson M., and Greenberger J.S. Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) intratracheal gene therapy reduction of irradiation-induced inflammatory cytokines does not protect orthotopic Lewis lung carcinomas. In Vivo 17 (2003) 13-21
74. Epperly M.W., Sikora C.A., DeFilippi S.J., Gretton J.E., Bar-Sagi D., Archer H., Carlos T., Guo H., and Greenberger J.S. Pulmonary irradiation-induced expression of VCAM-I and ICAM-I is decreased by manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) gene therapy. Biol. Blood Marrow Transplant. 8 (2002) 175-187
75. Takayasu K., Arii S., Ikai I., Omata M., Okita K., Ichida T., Matsuyama Y., Nakanuma Y., Kojiro M., Makuuchi M., and Yamaoka Y. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131 (2006) 461-469
76. Selzner N., Rudiger H., Graf R., and Clavien P.A. Protective strategies against ischemic injury of the liver. Gastroenterology 125 (2003) 917-936
77. Jaeschke H., and Lemasters J.J. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125 (2003) 1246-1257
78. Vardanian A.J., Busuttil R.W., and Kupiec-Weglinski J.W. Molecular mediators of liver ischemia and reperfusion injury: a brief review. Mol. Med. 14 (2008) 337-345
79. Glantzounis G.K., Salacinski H.J., Yang W., Davidson B.R., and Seifalian A.M. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transplant. 11 (2005) 1031-1047
80. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am. J. Physiol. Gastrointest. Liver Physiol. 284 (2003) G15-26
81. Karwinski W., and Soreide O. Allopurinol improves scavenging ability of the liver after ischemia/reperfusion injury. Liver 17 (1997) 139-143
82. Dorman R.B., Wunder C., Saba H., Shoemaker J.L., MacMillan-Crow L.A., and Brock R.W. NAD(P)H oxidase contributes to the progression of remote hepatic parenchymal injury and endothelial dysfunction, but not microvascular perfusion deficits. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G1025-1032
83. Liu P.G., He S.Q., Zhang Y.H., and Wu J. Protective effects of apocynin and allopurinol on ischemia/reperfusion-induced liver injury in mice. World J. Gastroenterol. 14 (2008) 2832-2837
84. Harada H., Hines I.N., Flores S., Gao B., McCord J., Scheerens H., and Grisham M.B. Role of NADPH oxidase-derived superoxide in reduced size liver ischemia and reperfusion injury. Arch. Biochem. Biophys. 423 (2004) 103-108
85. Malhi H., Gores G.J., and Lemasters J.J. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 43 (2006) S31-44
86. Teoh N.C., and Farrell G.C. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J. Gastroenterol. Hepatol. 18 (2003) 891-902
87. Nguyen W.D., Kim D.H., Alam H.B., Provido H.S., and Kirkpatrick J.R. Polyethylene glycol-superoxide dismutase inhibits lipid peroxidation in hepatic ischemia/reperfusion injury. Crit. Care 3 (1999) 127-130
88. Lehmann T.G., Wheeler M.D., Schoonhoven R., Bunzendahl H., Samulski R.J., and Thurman R.G. Delivery of Cu/Zn-superoxide dismutase genes with a viral vector minimizes liver injury and improves survival after liver transplantation in the rat. Transplantation 69 (2000) 1051-1057
89. Wheeler M.D., Katuna M., Smutney O.M., Froh M., Dikalova A., Mason R.P., Samulski R.J., and Thurman R.G. Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury. Hum. Gene Ther. 12 (2001) 2167-2177
90. Lehmann T.G., Wheeler M.D., Froh M., Schwabe R.F., Bunzendahl H., Samulski R.J., Lemasters J.J., Brenner D.A., and Thurman R.G. Effects of three superoxide dismutase genes delivered with an adenovirus on graft function after transplantation of fatty livers in the rat. Transplantation 76 (2003) 28-37
91. Liu Q., and Muruve D.A. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 10 (2003) 935-940
92. Venugopal S.K., Wu J., Catana A.M., Eisenbud L., He S.Q., Duan Y.Y., Bishop C., Follenzi A., Gupta S., and Zern M.A. Lentivirus-mediated copper-zinc superoxide dismutase gene delivery protects the liver in mice against oxidative stress. Liver International 27 (2007) 1311-1322
93. Liu L., Zern M.A., Lizarzaburu M.E., Nantz M.H., and Wu J. Poly(cationic lipid)-mediated in vivo gene delivery to mouse liver. Gene Ther. 10 (2003) 180-187
94. Wu J., Lizarzaburu M.E., Kurth M.J., Liu L., Wege H., Zern M.A., and Nantz M.H. Cationic lipid polymerization as a novel approach for constructing new DNA delivery agents. Bioconjug. Chem. 12 (2001) 251-257
95. Luedde T., and Trautwein C. The role of oxidative stress and antioxidant treatment in liver surgery and transplantation. Liver Transplant. 12 (2006) 1733-1735
96. Shiotani S., Shimada M., Taketomi A., Soejima Y., Yoshizumi T., Hashimoto K., Shimokawa H., and Maehara Y. Rho-kinase as a novel gene therapeutic target in treatment of cold ischemia/reperfusion-induced acute lethal liver injury: effect on hepatocellular NADPH oxidase system. Gene Ther. 14 (2007) 1425-1433
97. Frishman W.H., Novak S., Brandt L.J., Spiegel A., Gutwein A., Kohi M., and Rozenblit G. Pharmacologic management of mesenteric occlusive disease. Cardiol. Rev. 16 (2008) 59-68
98. Hsiao G., Yen M.H., Lee Y.M., and Sheu J.R. Antithrombotic effect of PMC, a potent alpha-tocopherol analogue on platelet plug formation in vivo. Br. J. Haematol. 117 (2002) 699-704
99. Byrka-Owczarek K., Steplewska-Mazur K., Krason M., Bohosiewicz J., Koszutski T., and Wojtynek G. The evaluation of the protective action of antioxidants on small intestine of rabbits experimentally injured by ischemia and reperfusion. J. Pediatr. Surg. 39 (2004) 1226-1229
100. Tireli G.A., Salman T., Ozbey H., Abbasoglu L., Toker G., and Celik A. The effect of pentoxifylline on intestinal anastomotic healing after ischemia. Pediatr. Surg. Int. 19 (2003) 88-90
101. Poussios D., Andreadou I., Papalois A., Rekka E., Gavalakis N., Aroni K., Kourounakis P.N., Fotiadis C., and Sechas M.N. Protective effect of a novel antioxidant non-steroidal anti-inflammatory agent (compound IA) on intestinal viability after acute mesenteric ischemia and reperfusion. Eur. J. Pharmacol. 465 (2003) 275-280
102. Muia C., Mazzon E., Di Paola R., Genovese T., Menegazzi M., Caputi A.P., Suzuki H., and Cuzzocrea S. Green tea polyphenol extract attenuates ischemia/reperfusion injury of the gut. Naunyn Schmiedebergs Arch. Pharmacol. 371 (2005) 364-374
103. Ypsilantis P., Lambropoulou M., Tentes I., Kortsaris A., Papadopoulos N., and Simopoulos C. Mesna protects intestinal mucosa from ischemia/reperfusion injury. J. Surg. Res. 134 (2006) 278-284
104. Aydin C., Teke Z., Aytekin F., Yenisey C., Kabay B., Simsek N.G., and Tekin K. Tempol prevents harmful effects of remote ischemia reperfusion injury on healing of experimental colonic anastomoses. Int. J. Colorectal Dis. 22 (2007) 325-331
105. Kozuch P.L., and Brandt L.J. Review article: diagnosis and management of mesenteric ischaemia with an emphasis on pharmacotherapy. Aliment. Pharmacol. Ther. 21 (2005) 201-215
106. Guo H.L., Wolfe D., Epperly M.W., Huang S., Liu K., Glorioso J.C., Greenberger J., and Blumberg D. Gene transfer of human manganese superoxide dismutase protects small intestinal villi from radiation injury. J. Gastrointest. Surg. 7 (2003) 229-235 discussion 235-6
107. Mallick I.H., Yang W., Winslet M.C., and Seifalian A.M. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig. Dis. Sci. 49 (2004) 1359-1377
108. Grogaard B., Parks D.A., Granger D.N., McCord J.M., and Forsberg J.O. Effects of ischemia and oxygen radicals on mucosal albumin clearance in intestine. Am. J. Physiol. 242 (1982) G448-454
109. Riaz A.A., Wan M.X., Schafer T., Dawson P., Menger M.D., Jeppsson B., and Thorlacius H. Allopurinol and superoxide dismutase protect against leucocyte-endothelium interactions in a novel model of colonic ischaemia-reperfusion. Br. J. Surg. 89 (2002) 1572-1580
110. Otamiri T.A., Tagesson C., and Sjodahl R. Increased plasma malondialdehyde in patients with small intestinal strangulation obstruction. Acta Chir. Scand. 154 (1988) 283-285
111. Vlasov T.D., Smirnov D.A., and Nutfullina G.M. Preconditioning of the small intestine to ischemia in rats. Neurosci. Behav. Physiol. 32 (2002) 449-453
112. Wu B., Iwakiri R., Tsunada S., Utsumi H., Kojima M., Fujise T., Ootani A., and Fujimoto K. iNOS enhances rat intestinal apoptosis after ischemia-reperfusion. Free Radic. Biol. Med. 33 (2002) 649-658
113. Abdelrahman M., Mazzon E., Bauer M., Bauer I., Delbosc S., Cristol J.P., Patel N.S., Cuzzocrea S., and Thiemermann C. Inhibitors of NADPH oxidase reduce the organ injury in hemorrhagic shock. Shock 23 (2005) 107-114
114. Oktar B.K., Gulpinar M.A., Bozkurt A., Ghandour S., Cetinel S., Moini H., Yegen B.C., Bilsel S., Granger D.N., and Kurtel H. Endothelin receptor blockers reduce I/R-induced intestinal mucosal injury: role of blood flow. Am. J. Physiol. Gastrointest. Liver Physiol. 282 (2002) G647-655
115. Yun K.J., Choi S.C., and Oh J.M. Expression of heme oxygenase-1 in ischemic colitis. Korean J. Gastroenterol. 45 (2005) 335-339
116. Wasserberg N., Pileggi A., Salgar S.K., Ruiz P., Ricordi C., Inverardi L., and Tzakis A.G. Heme oxygenase-1 upregulation protects against intestinal ischemia/reperfusion injury: a laboratory based study. Int. J. Surg. 5 (2007) 216-224
117. Somavarapu S., Bramwell V.W., and Alpar H.O. Oral plasmid DNA delivery systems for genetic immunisation. J. Drug Target. 11 (2003) 547-553
118. Brines M., Grasso G., Fiordaliso F., Sfacteria A., Ghezzi P., Fratelli M., Latini R., Xie Q.W., Smart J., Su-Rick C.J., Pobre E., Diaz D., Gomez D., Hand C., Coleman T., and Cerami A. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 14907-14912
119. Guneli E., Cavdar Z., Islekel H., Sarioglu S., Erbayraktar S., Kiray M., Sokmen S., Yilmaz O., and Gokmen N. Erythropoietin protects the intestine against ischemia/ reperfusion injury in rats. Mol. Med. 13 (2007) 509-517
120. Sreenarasimhaiah J. Chronic mesenteric ischemia. Curr. Treat. Options Gastroenterol. 10 (2007) 3-9
121. Bokesch P.M., Marchand J., Seirafi P.A., Deiss J.M., Warner K.G., Bronson R.T., and Kream R.M. Immediate-early gene expression in ovine brain after cardiopulmonary bypass and hypothermic circulatory arrest. Anesthesiology 85 (1996) 1439-1446
122. McCullough J.L., Hollier L.H., and Nugent M. Paraplegia after thoracic aortic occlusion: influence of cerebrospinal fluid drainage. Experimental and early clinical results. J. Vasc. Surg. 7 (1988) 153-160
123. Gilgun-Sherki Y., Rosenbaum Z., Melamed E., and Offen D. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol. Rev. 54 (2002) 271-284
124. Schaller B. Prospects for the future: the role of free radicals in the treatment of stroke. Free Radic. Biol. Med. 38 (2005) 411-425
125. Shi H., and Liu K.J. Cerebral tissue oxygenation and oxidative brain injury during ischemia and reperfusion. Front. Biosci. 12 (2007) 1318-1328
126. Koller W.C., and Cersosimo M.G. Neuroprotection in Parkinson's disease: an elusive goal. Curr. Neurol. Neurosci. Rep. 4 (2004) 277-283
127. LeWitt P.A., and Taylor D.C. Protection against Parkinson's disease progression: clinical experience. Neurotherapeutics 5 (2008) 210-225
128. Rizzardini M., Mangolini A., Lupi M., Ubezio P., Bendotti C., and Cantoni L. Low levels of ALS-linked Cu/Zn superoxide dismutase increase the production of reactive oxygen species and cause mitochondrial damage and death in motor neuron-like cells. J. Neurol. Sci. 232 (2005) 95-103
129. Liu R., Li B., Flanagan S.W., Oberley L.W., Gozal D., and Qiu M. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival. J. Neurochem. 80 (2002) 488-500
130. An J.J., Lee Y.P., Kim S.Y., Lee S.H., Kim D.W., Lee M.J., Jeong M.S., Jang S.H., Kang J.H., Kwon H.Y., Kang T.C., Won M.H., Cho S.W., Kwon O.S., Lee K.S., Park J., Eum W.S., and Choi S.Y. Transduction of familial amyotrophic lateral sclerosis-related mutant PEP-1-SOD proteins into neuronal cells. Mol. Cells 25 (2008) 55-63
131. Cousar J.L., Lai Y., Marco C.D., Bayir H., Adelson P.D., Janesko-Feldman K.L., Kochanek P.M., and Clark R.S. Heme oxygenase 1 in cerebrospinal fluid from infants and children after severe traumatic brain injury. Dev. Neurosci. 28 (2006) 342-347
132. Kim D.W., Eum W.S., Jang S.H., Kim S.Y., Choi H.S., Choi S.H., An J.J., Lee S.H., Lee K.S., Han K., Kang T.C., Won M.H., Kang J.H., Kwon O.S., Cho S.W., Kim T.Y., Park J., and Choi S.Y. Transduced Tat-SOD fusion protein protects against ischemic brain injury. Mol. Cells 19 (2005) 88-96
133. Bayir H., Kagan V.E., Clark R.S., Janesko-Feldman K., Rafikov R., Huang Z., Zhang X., Vagni V., Billiar T.R., and Kochanek P.M. Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury. J. Neurochem. 101 (2007) 168-181
134. Tangpong J., Cole M.P., Sultana R., Estus S., Vore M., St Clair W., Ratanachaiyavong S., St Clair D.K., and Butterfield D.A. Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain. J. Neurochem. 100 (2007) 191-201
135. Joshi G., Hardas S., Sultana R., St Clair D.K., Vore M., and Butterfield D.A. Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: implication for chemobrain. J. Neurosci. Res. 85 (2007) 497-503
136. Sugawara T., Noshita N., Lewen A., Gasche Y., Ferrand-Drake M., Fujimura M., Morita-Fujimura Y., and Chan P.H. Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation. J. Neurosci. 22 (2002) 209-217
137. Gu W., Zhao H., Yenari M.A., Sapolsky R.M., and Steinberg G.K. Catalase over-expression protects striatal neurons from transient focal cerebral ischemia. Neuroreport 15 (2004) 413-416
138. Yang G.Y., Pang L., Ge H.L., Tan M., Ye W., Liu X.H., Huang F.P., Wu D.C., Che X.M., Song Y., Wen R., and Sun Y. Attenuation of ischemia-induced mouse brain injury by SAG, a redox-inducible antioxidant protein. J. Cereb. Blood Flow Metab. 21 (2001) 722-733
139. Xu D.G., Crocker S.J., Doucet J.P., St-Jean M., Tamai K., Hakim A.M., Ikeda J.E., Liston P., Thompson C.S., Korneluk R.G., MacKenzie A., and Robertson G.S. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nat. Med. 3 (1997) 997-1004
140. Jin G., Arai K., Murata Y., Wang S., Stins M.F., Lo E.H., and van Leyen K. Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia. Stroke 39 (2008) 2538-2543
141. Calkins M.J., Jakel R.J., Johnson D.A., Chan K., Kan Y.W., and Johnson J.A. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 244-249
142. Li J., Calkins M.J., Johnson D.A., and Johnson J.A. Role of Nrf2-dependent ARE-driven antioxidant pathway in neuroprotection. Methods Mol. Biol. 399 (2007) 67-78
143. Hayashi T., Saito A., Okuno S., Ferrand-Drake M., Dodd R.L., and Chan P.H. Oxidative injury to the endoplasmic reticulum in mouse brains after transient focal ischemia. Neurobiol. Dis. 15 (2004) 229-239
144. Zhang Q.G., Tian H., Li H.C., and Zhang G.Y. Antioxidant N-acetylcysteine inhibits the activation of JNK3 mediated by the GluR6-PSD95-MLK3 signaling module during cerebral ischemia in rat hippocampus. Neurosci. Lett. 408 (2006) 159-164
145. Anderson D.M., Hall L.L., Ayyalapu A.R., Irion V.R., Nantz M.H., and Hecker J.G. Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: methods and evidence for nonviral mRNA gene delivery to the central nervous system. Hum. Gene Ther. 14 (2003) 191-202
146. E.S. Haucke, S. Zou, K.A. Scarfo, M.H. Nantz, J.G. Hecker. Whole animal in vivo imaging after transient non-viral lipid-mediated gene transfer to the rat central nervous system. Molecular Therapy (2008) in press.
147. Hecker J.G., Hall L.L., and Irion V.R. Nonviral gene delivery to the lateral ventricles in rat brain: initial evidence for widespread distribution and expression in the central nervous system. Mol. Ther. 3 (2001) 375-384
148. Malone R.W., Felgner P.L., and Verma I.M. Cationic liposome-mediated RNA transfection. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 6077-6081
149. Hecker R.B., Hays J.V., Champ J.D., and Rubal B.J. Myocardial ischemia and stunning induced by topical intranasal phenylephrine pledgets. Mil. Med. 162 (1997) 832-835
150. Mamot C., Nguyen J.B., Pourdehnad M., Hadaczek P., Saito R., Bringas J.R., Drummond D.C., Hong K., Kirpotin D.B., McKnight T., Berger M.S., Park J.W., and Bankiewicz K.S. Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery. J. Neurooncol. 68 (2004) 1-9
151. Guo S., Wharton W., Moseley P., and Shi H. Heat shock protein 70 regulates cellular redox status by modulating glutathione-related enzyme activities. Cell Stress Chaperones 12 (2007) 245-254
152. Tang D., Kang R., Xiao W., Jiang L., Liu M., Shi Y., Wang K., Wang H., and Xiao X. Nuclear heat shock protein 72 as a negative regulator of oxidative stress (hydrogen peroxide)-induced HMGB1 cytoplasmic translocation and release. J. Immunol. 178 (2007) 7376-7384
153. Patel Y.J., Payne Smith M.D., de Belleroche J., and Latchman D.S. Hsp27 and Hsp70 administered in combination have a potent protective effect against FALS-associated SOD1-mutant-induced cell death in mammalian neuronal cells. Brain Res. Mol. Brain Res. 134 (2005) 256-274
154. Yenari M.A., Dumas T.C., Sapolsky R.M., and Steinberg G.K. Gene therapy for treatment of cerebral ischemia using defective herpes simplex viral vectors. Ann. N.Y. Acad. Sci. 939 (2001) 340-357
155. Yenari M.A., Fink S.L., Sun G.H., Chang L.K., Patel M.K., Kunis D.M., Onley D., Ho D.Y., Sapolsky R.M., and Steinberg G.K. Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann. Neurol. 44 (1998) 584-591
156. Fink S.L., Chang L.K., Ho D.Y., and Sapolsky R.M. Defective herpes simplex virus vectors expressing the rat brain stress-inducible heat shock protein 72 protect cultured neurons from severe heat shock. J. Neurochem. 68 (1997) 961-969
157. Hoehn B., Ringer T.M., Xu L., Giffard R.G., Sapolsky R.M., Steinberg G.K., and Yenari M.A. Overexpression of HSP72 after induction of experimental stroke protects neurons from ischemic damage. J. Cereb. Blood Flow Metab. 21 (2001) 1303-1309
158. Rennels M.L., Gregory T.F., Blaumanis O.R., Fujimoto K., and Grady P.A. Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res. 326 (1985) 47-63
159. Berges B.K., Wolfe J.H., and Fraser N.W. Transduction of brain by herpes simplex virus vectors. Mol. Ther. 15 (2007) 20-29